Search
Search Results
##search.searchResults.foundPlural##
-
REFRACTORY THROMBOCYTOPENIA AND NEUTROPENIA: A DIAGNOSTIC CHALLENGE
12318PDF: 1670HTML: 4161Cover letter: 195Figure 1: 201 -
-
INTEREST IN DETERMINING THE CD34+ CD38- PHENOTYPE IN THE DIAGNOSIS AND PROGNOSIS OF ACUTE LEUKEMIA IN ABIDJAN – CÔTE D’IVOIRE
1937PDF: 708HTML: 678Table1: patient's characteristics: 153Table 2: profile of each patient: 178 -
NEW STRATEGIES FOR STEM CELL MOBILIZATION
2379PDF: 849HTML: 2450 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4074PDF: 1576HTML: 928 -
Acquired Sideroblastic Anemia: An exploratory Comparative Statistical Analysis Between Clonal and Non-clonal cases Acquired Sideroblastic Anemia
940PDF: 574HTML: 335 -
PERIOPERATIVE MANAGEMENT OF SICKLE CELL DISEASE: A NARRATIVE REVIEW
7942PDF: 3229HTML: 1214 -
THE PROTHROMBOTIC STATE ASSOCIATED WITH SARS-COV-2 INFECTION: PATHOPHYSIOLOGICAL ASPECTS COVID and Thrombosis
1947PDF: 808HTML: 217 -
A 9month-old-boy with atypical hemophagocytic lymphohistiocytosis
2006PDF: 788HTML: 1030 -
Glucocorticoids and antivirals for HBV reactivation in onco-hematologic patients
926PDF: 567HTML: 2185Cover Letter: 189 -
INCIDENCE OF ACUTE MYELOID LEUKEMIA AFTER BREAST CANCER
3220PDF: 930HTML: 2946 -
MANAGEMENT OF PORTAL VEIN THROMBOSIS IN CIRRHOTIC PATIENTS
812PDF: 536HTML: 4012 -
MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML)
3905PDF: 1484HTML: 9184Untitled: 273Untitled: 176Untitled: 163Untitled: 160Untitled: 176Untitled: 332 -
TUBERCULOSIS IN HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS.
2610PDF: 934HTML: 3598 -
PRACTICAL RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH ITP DURING THE COVID-19 PANDEMIC Recommendation for ITP management during COVID
2452PDF: 917HTML: 515 -
The venetoclax/azacitidine combination targets the disease clone in Acute Myeloid Leukemia, being effective and safe in a patient with COVID VEN/AZA effectively targets AML clones
1207PDF: 754HTML: 306 -
DEFERASIROX: OVER A DECADE OF EXPERIENCE IN THALASSEMIA
2879PDF: 1578HTML: 230 -
As a Rare Site of Invasive Fungal Infection, Chronic Granulomatous Aspergillus Synovitis: A Case Report
1693PDF: 621HTML: 1508Figure 1: MRI demonstrating Aspergillus synovitis: 183Figure 2:MRI demonstrating Aspergillus synovitis: 187 -
FEASIBILITY AND OUTCOME OF FIRST-LINE AUTOTRANSPLANT-BASED TREATMENT IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS AGED > 65 YEARS: MONOCENTRIC RETROSPECTIVE REAL-WORLD ANALYSIS Outcomes of ASCT in NDMM elderly fit patients
1039PDF: 613Html: 146 -
Antivirals and monoclonal antibody combination therapy in haematological patients in the omicron era Antiviral and monoclonal Antibodies in Haematological Patients in the omicron era
1268PDF: 931HTML: 87 -
-
SARS-CoV-2 INFECTED PATIENTS: FROM A HEMATOLOGIST PERSPECTIVE COVID-19 and Hematology
1034PDF: 959HTML: 321 -
Coronavirus disease 2019 (COVID-19) severity in patients with thalassemias: A Nationwide Iranian Experience Coronavirus in patients with thalassemias
1330PDF: 462HTML: 162 -
Acute Panmyelosis with Myelofibrosis - A Rare Subtype of Acute Myeloid Leukemia
2816PDF: 961HTML: 3122flowcytometric result of peripheral blood sample: 173 -
ASSESSMENT OF THE EFFICACY OF PROCALCITONIN, C-REACTIVE PROTEIN AND ALBUMIN LEVELS-GUIDED ANTIBIOTICS USE IN SEPSIS
911PDF: 487Html: 139Suppl. Files: 171 -
CYTOMEGALOVIRUS REACTIVATION IN ADULT RECIPIENTS OF AUTOLOGOUS STEM CELL TRANSPLANTATION: A SINGLE CENTER EXPERIENCE
1537PDF: 875HTML: 973figures: 177table 1: 180table2: 178table3: 179







